FindTrial
Sign In

Radioconjugate

OTHER3 trials

Sponsors

University of Washington, Roswell Park Cancer Institute, City of Hope Medical Center

Conditions

Castration-Resistant Prostate CarcinomaExtensive-stage Small-cell Lung CancerLimited-stage Small-cell Lung CancerLocally Advanced Pancreatic AdenocarcinomaLung Non-Small Cell CarcinomaMetastatic Pancreatic AdenocarcinomaMetastatic Prostate AdenocarcinomaStage III Pancreatic Cancer AJCC v8

Phase 1

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer
WithdrawnNCT06427369
Roswell Park Cancer InstituteExtensive-stage Small-cell Lung Cancer, Limited-stage Small-cell Lung Cancer, Lung Non-Small Cell Carcinoma +2
Start: 2024-10-01End: 2027-09-01Updated: 2024-09-27
64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer
Not yet recruitingNCT07608627
City of Hope Medical CenterLocally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8 +1
Start: 2026-12-16End: 2028-07-14Target: 15Updated: 2026-05-27

Phase 2

Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
RecruitingNCT06039371
University of WashingtonCastration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
Start: 2024-05-21End: 2027-12-31Target: 69Updated: 2026-01-14